109 related articles for article (PubMed ID: 1968382)
1. Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin.
Junier MP; Dray F; Blair I; Capdevila J; Dishman E; Falck JR; Ojeda SR
Endocrinology; 1990 Mar; 126(3):1534-40. PubMed ID: 1968382
[TBL] [Abstract][Full Text] [Related]
2. Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence.
Capdevila J; Chacos N; Falck JR; Manna S; Negro-Vilar A; Ojeda SR
Endocrinology; 1983 Jul; 113(1):421-3. PubMed ID: 6134613
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of arachidonic acid by rat adrenal glomerulosa cells: synthesis of hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids.
Campbell WB; Brady MT; Rosolowsky LJ; Falck JR
Endocrinology; 1991 Apr; 128(4):2183-94. PubMed ID: 1900788
[TBL] [Abstract][Full Text] [Related]
4. Regulation of growth hormone-releasing hormone and somatostatin from perifused, bovine hypothalamic slices. II. Dopamine receptor regulation.
West CR; Lookingland KJ; Tucker HA
Domest Anim Endocrinol; 1997 Sep; 14(5):349-57. PubMed ID: 9347255
[TBL] [Abstract][Full Text] [Related]
5. Role of arachidonic acid or its metabolites in growth-hormone-releasing factor-induced release of somatostatin from the median eminence.
Aguila MC; Milenkovic L; McCann SM; Snyder GD
Neuroendocrinology; 1990 Sep; 52(3):238-42. PubMed ID: 1977095
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF
Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601
[TBL] [Abstract][Full Text] [Related]
7. Epoxygenase metabolites of arachidonic acid affect electrophysiologic properties of rat tracheal epithelial cells1.
Pascual JM; McKenzie A; Yankaskas JR; Falck JR; Zeldin DC
J Pharmacol Exp Ther; 1998 Aug; 286(2):772-9. PubMed ID: 9694933
[TBL] [Abstract][Full Text] [Related]
8. Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways.
Wei Y; Lin DH; Kemp R; Yaddanapudi GS; Nasjletti A; Falck JR; Wang WH
J Gen Physiol; 2004 Dec; 124(6):719-27. PubMed ID: 15545402
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids.
Jiang H; Zhu AG; Mamczur M; Falck JR; Lerea KM; McGiff JC
Br J Pharmacol; 2007 Aug; 151(7):1033-40. PubMed ID: 17558440
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic responses.
Takahashi K; Capdevila J; Karara A; Falck JR; Jacobson HR; Badr KF
Am J Physiol; 1990 Apr; 258(4 Pt 2):F781-9. PubMed ID: 2109933
[TBL] [Abstract][Full Text] [Related]
11. Lipoxygenase products of arachidonic acid stimulate LHRH release from rat median eminence.
Gerozissis K; Vulliez B; Saavedra JM; Murphy RC; Dray F
Neuroendocrinology; 1985 Mar; 40(3):272-6. PubMed ID: 3921861
[TBL] [Abstract][Full Text] [Related]
12. Dopamine (D1) receptor activation and nitrinergic agents influence somatostatin levels in rat retina.
Kiagiadaki F; Koulakis E; Thermos K
Exp Eye Res; 2008 Jan; 86(1):18-24. PubMed ID: 17961553
[TBL] [Abstract][Full Text] [Related]
13. Effects of dopamine on immunoreactive growth hormone-releasing factor and somatostatin secretion from rat hypothalamic slices perifused in vitro.
Kitajima N; Chihara K; Abe H; Okimura Y; Fujii Y; Sato M; Shakutsui S; Watanabe M; Fujita T
Endocrinology; 1989 Jan; 124(1):69-76. PubMed ID: 2462495
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of arachidonic acid to epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes.
Amruthesh SC; Boerschel MF; McKinney JS; Willoughby KA; Ellis EF
J Neurochem; 1993 Jul; 61(1):150-9. PubMed ID: 8515261
[TBL] [Abstract][Full Text] [Related]
15. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
[TBL] [Abstract][Full Text] [Related]
16. Involvement of eicosanoids in release of oxytocin and vasopressin from the neural lobe of the rat pituitary.
Negro-Vilar A; Snyder GD; Falck JR; Manna S; Chacos N; Capdevila J
Endocrinology; 1985 Jun; 116(6):2663-8. PubMed ID: 3922746
[TBL] [Abstract][Full Text] [Related]
17. D1 receptors mediate dopamine stimulation of immunoreactive atrial natriuretic factor (ANF) release and pro-ANF messenger ribonucleic acid expression of rat hypothalamic neurons in culture.
Lee D; Huang W; Lim AT
Endocrinology; 1995 Feb; 136(2):591-7. PubMed ID: 7835293
[TBL] [Abstract][Full Text] [Related]
18. Adenosine inhibits ENaC via cytochrome P-450 epoxygenase-dependent metabolites of arachidonic acid.
Wei Y; Sun P; Wang Z; Yang B; Carroll MA; Wang WH
Am J Physiol Renal Physiol; 2006 May; 290(5):F1163-8. PubMed ID: 16234312
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries.
Rosolowsky M; Falck JR; Willerson JT; Campbell WB
Circ Res; 1990 Mar; 66(3):608-21. PubMed ID: 2106399
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of somatostatin release from median eminence tissue incubated in vitro by taurine and related amino acids.
Aguila MC; McCann SM
Endocrinology; 1985 Mar; 116(3):1158-62. PubMed ID: 2857639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
